BRPI0503222A - Paricalcitol oral formulations - Google Patents

Paricalcitol oral formulations

Info

Publication number
BRPI0503222A
BRPI0503222A BR0503222-9A BRPI0503222A BRPI0503222A BR PI0503222 A BRPI0503222 A BR PI0503222A BR PI0503222 A BRPI0503222 A BR PI0503222A BR PI0503222 A BRPI0503222 A BR PI0503222A
Authority
BR
Brazil
Prior art keywords
paricalcitol
oral formulations
bioequivalent
variety
available
Prior art date
Application number
BR0503222-9A
Other languages
Portuguese (pt)
Inventor
Leticia Delgado-Herrera
Steve Chamberlin
Dennis Stephens
Joel Melnick
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BRPI0503222A publication Critical patent/BRPI0503222A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

"FORMULAçõES ORAIS DE PARICALCITOL". A presente invenção se refere a formulações orais que compreendem paricalcitol e que são disponíveis em uma variedade de formas de dosagem diferentes que são bioequivalentes entre si."ORAL FORMULATIONS OF PARICALCITOL". The present invention relates to oral formulations comprising paricalcitol and which are available in a variety of different dosage forms which are bioequivalent to each other.

BR0503222-9A 2004-05-28 2005-05-27 Paricalcitol oral formulations BRPI0503222A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57562004P 2004-05-28 2004-05-28

Publications (1)

Publication Number Publication Date
BRPI0503222A true BRPI0503222A (en) 2006-01-24

Family

ID=35044534

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0503222-9A BRPI0503222A (en) 2004-05-28 2005-05-27 Paricalcitol oral formulations

Country Status (5)

Country Link
EP (1) EP1791547A1 (en)
BR (1) BRPI0503222A (en)
CA (1) CA2578806A1 (en)
TW (1) TW200608982A (en)
WO (1) WO2005117901A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003258282A1 (en) * 2002-08-16 2004-03-03 Abbott Laboratories Shortening of hospital stay and improving survival in patients with chronic kidney disease
KR20050086545A (en) * 2002-11-06 2005-08-30 노바세아, 인크. Methods of usi0ng vitamin d compounds in the treatment of myelodysplastic syndromes

Also Published As

Publication number Publication date
CA2578806A1 (en) 2005-12-15
TW200608982A (en) 2006-03-16
EP1791547A1 (en) 2007-06-06
WO2005117901A1 (en) 2005-12-15

Similar Documents

Publication Publication Date Title
LTPA2018502I1 (en) Oral Cladribine Compositions
RS50660B (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
MA31502B1 (en) Antibodies antibodies-notch specific NRR and methods of use.
MA29014B1 (en) ANTIBODY FORMULATIONS
BRPI0620229A8 (en) formulation
MA31231B1 (en) Antibodies and anti-robo4 antibodies and their uses.
NO20083895L (en) Anti-IGF-1R human monoclonal antibody formulation
EA200901393A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENES AND / OR ESTROGENS AND 5 METHYL- (6S) -TETRAHYDROPHOLATE
CY1112738T1 (en) A COMBINED COMPOSITION CONTAINING Ibuprofen And Paracetamol
DK1467724T3 (en) Pharmaceutical composition with agomelatine for dispersal in the oral cavity
EA200701172A1 (en) 2-ALKOXI-3,4,5-TRIHYDROXIALKYLAMIDES, THEIR RECEIVING, COMPOSITIONS, THEIR CONTAINING, AND APPLICATION
DE60312049D1 (en) STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING AN AMORPHANT AGENT
GT200800107A (en) ORAL FORMULATIONS THAT INCLUDE TIGECICLINE
NO20062605L (en) Pharmaceutical formulation containing flavoring substances with improved pharmaceutical properties
BRPI0506779A (en) Ice cream formulation and ice cream
BRPI0408895A (en) Cladribine formulations for improved oral and transmucosal administration
EA200401515A1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERIN IN POLYMORPHIC MODIFICATION A
DE50204688D1 (en) N-ALKYLAZIRIDINOPREPOLYMERS AS DENTAL MASS
PA8571901A1 (en) NEW PHARMACEUTICAL COMPOSITION
BRPI0517782A (en) benzothiazole formulations and their use
BRPI0503222A (en) Paricalcitol oral formulations
ATE357220T1 (en) MODIFIED RELEASE PHARMACEUTICAL COMPOSITION
BRPI0415428A (en) therapeutic formulations
BRPI0401464A (en) Pharmaceutical and / or cosmetic compositions having rejuvenating properties
BRPI0501052A (en) papain based cosmetic composition

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: ABBVIE INC. (US)

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2463 DE 20/03/2018 POR TER SIDO INDEVIDA.

B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]